Infectious complications associated with alemtuzumab use for allogeneic hematopoietic stem cell transplantation: comparison with anti‐thymocyte globulin

Soo‐An Park, Su‐Mi Choi, Dong‐Gun Lee, Jung‐Hyun Choi, Jin‐Hong Yoo, Si‐Hyun Kim, H.‐J. Kim, Seok‐Goo Cho, Ki‐Seong Eom, Jae‐woo Lee,

Transplant Infectious Disease · 2009 · 44 citations · 32 references

Abstract

Alemtuzumab recipients had a high incidence of CMV disease as well as BK virus-associated HC compared with the ATG recipients. The dose of alemtuzumab should be tailored to patients' risk; in addition, the implementation of the appropriate prophylaxis for CMV and early detection strategies for BK virus are recommended.

References

32